Acadia Pharmaceuticals | ACAD - Lieferungen Und Leistungen

Aktienkurs
21.85
Täglich Wechseln
-0.60 -2.67%
Monatlich
-1.58%
Jährlich
46.55%
Q2 Prognose
21.49




Lieferungen Und Leistungen Veränderung Datum
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
ALKERMES USD 334.02M 21.08M 2025-12
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Cara Therapeutics USD 2.24M 2.26M 2025-03
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Cytokinetics USD 1.81M 6.6M 2025-09
Eisai JPY 249.06B 25B 2025-12
Eli Lilly USD 21.18B 1.02B 2026-03
Incyte USD 1.05B 27.09M 2026-03
J&J USD 21.33B 3.72B 2025-12
Moderna USD 71M 113M 2026-03
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Prothena USD 5.16M 0 2023-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12